ELISE BERKLAND: Open Payments
NPI 1558760017 · CARY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,314 in 69 payments from 17 companies in 2025. Trend: 2023 $739 · 2024 $1,119 · 2025 $1,314
Food & beverage: $1,314
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $334 |
| ABBVIE INC. | 11 | $200 |
| Corcept Therapeutics | 6 | $121 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $100 |
| AstraZeneca Pharmaceuticals LP | 5 | $99 |
| PFIZER INC. | 3 | $65 |
| Lilly USA, LLC | 3 | $64 |
| Axsome Therapeutics, Inc. | 3 | $62 |
| Kowa Pharmaceuticals America, Inc. | 4 | $58 |
| Exact Sciences Corporation | 3 | $55 |
Products named: Wegovy, Korlym, CAPLYTA, UBRELVY, AIRSUPRA, VRAYLAR, Auvelity, ZORYVE.
Industry payments across NC — which companies pay providers there.
